171 related articles for article (PubMed ID: 29112647)
1. Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
Cortessis VK; Barrett M; Brown Wade N; Enebish T; Perrigo JL; Tobin J; Zhong C; Zink J; Isiaka V; Muderspach LI; Natavio M; McKean-Cowdin R
Obstet Gynecol; 2017 Dec; 130(6):1226-1236. PubMed ID: 29112647
[TBL] [Abstract][Full Text] [Related]
2. Invasive cervical cancer and intrauterine device use.
Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis.
Wheeler LJ; Desanto K; Teal SB; Sheeder J; Guntupalli SR
Obstet Gynecol; 2019 Oct; 134(4):791-800. PubMed ID: 31503144
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
Castellsagué X; Díaz M; Vaccarella S; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Meijer CJ; Bosch FX
Lancet Oncol; 2011 Oct; 12(11):1023-31. PubMed ID: 21917519
[TBL] [Abstract][Full Text] [Related]
5. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
6. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
Mehanna MT; Rizk MA; Ramadan M; Schachter J
Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
[TBL] [Abstract][Full Text] [Related]
7. The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections.
Jatlaoui TC; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):701-712. PubMed ID: 27263041
[TBL] [Abstract][Full Text] [Related]
8. Immediate postabortal insertion of intrauterine devices.
Grimes DA; Lopez LM; Schulz KF; Stanwood NL
Cochrane Database Syst Rev; 2010 Jun; (6):CD001777. PubMed ID: 20556754
[TBL] [Abstract][Full Text] [Related]
9. Uterine structural abnormality and intrauterine device malposition: analysis of ultrasonographic and demographic variables of 517 patients.
Gerkowicz SA; Fiorentino DG; Kovacs AP; Arheart KL; Verma U
Am J Obstet Gynecol; 2019 Feb; 220(2):183.e1-183.e8. PubMed ID: 30419198
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
11. Intrauterine device survival in Iranian women: systematic review and meta-analysis.
Farajzadegan Z; Motamedi N; Nouri R; Kheyri M
J Family Med Prim Care; 2015; 4(2):203-7. PubMed ID: 25949968
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.
Jatlaoui TC; Whiteman MK; Jeng G; Tepper NK; Berry-Bibee E; Jamieson DJ; Marchbanks PA; Curtis KM
Obstet Gynecol; 2018 Oct; 132(4):895-905. PubMed ID: 30204688
[TBL] [Abstract][Full Text] [Related]
13. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine device use and endometrial cancer risk.
Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR
Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773
[TBL] [Abstract][Full Text] [Related]
15. The safety of intrauterine devices among young women: a systematic review.
Jatlaoui TC; Riley HEM; Curtis KM
Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
[TBL] [Abstract][Full Text] [Related]
16. Cervical carcinogenesis and contraception.
Misra JS; Engineer AD; Das K; Tandon P
Diagn Cytopathol; 1991; 7(4):346-52. PubMed ID: 1935511
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
18. A retrospective evaluation of the intrauterine device in a patient population in Buenos Aires, Argentina.
Jagroep SR; Pichardo MS; Arribas L; Heredia G; Coccio E; Palermo TM
J Fam Plann Reprod Health Care; 2016 Apr; 42(2):88-92. PubMed ID: 26420847
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
